Ortho Clinical Diagnostics
The Chief Financial Officer of Ortho Clinical Diagnostics, Jeff Capello (pictured), has announced he will leave the company for personal reasons.
Capello joined OCD’s executive team in June 2014 when OCD was bought by Carlyle.
He will be replaced by Charles Wagner, who will leave his post at Bruker Corporation, a public life sciences equipment manufacturer.
OCD CEO Martin Madaus commented, “I have known Charlie since 2004 and worked closely with him at Millipore Corporation where he was CFO until its successful sale to Merck in 2010.
“I am extremely pleased to have hired such a qualified and talented finance professional to take the reins as CFO.”
Investment analysts Evercore ISI told us Wagner will be temporarily replaced at Bruker by Anthony Mattacchione, Senior VP of Finance and Accounting.
Evercore’s Ross Muken described Wagner’s departure as “not a total shock, more of a mild surprise, as despite the recent progress, the pathway towards the early returns regarding Bruker's transformation has not always been smooth.”
In the near-term, he said, Bruker shares could be “under pressure” until a successor is found, as Wagner was seen as an “agent of change” who improved the company’s discipline and organisation.